ClinConnect ClinConnect Logo
Search / Trial NCT06744166

Effect of Transcutaneous Electrical Nerve Stimulation Based on Wrist-ankle Acupuncture Theory on Postoperative Pain After Video-assisted Thoracoscopic Surgery

Launched by CHANGHAI HOSPITAL · Dec 19, 2024

Trial Information

Current as of August 21, 2025

Not yet recruiting

Keywords

Video Assisted Thoracoscopic Surgery (Vats) Postoperative Pain

ClinConnect Summary

This clinical trial is looking at a new way to help manage pain after a specific type of lung surgery called Video-assisted Thoracoscopic Surgery (VATS). While VATS is less invasive than traditional surgery and generally leads to quicker recovery, some patients still experience significant pain afterward. The researchers want to find out if a method called Transcutaneous Electrical Nerve Stimulation (TENS), which is based on principles from acupuncture, can effectively reduce this postoperative pain compared to a placebo treatment (a sham stimulation that does not work).

To participate in this trial, you need to be at least 18 years old and scheduled for a lobectomy surgery using VATS for lung cancer. You should also be in good overall health (physical status of I-III) and able to give informed consent. However, if you have certain medical conditions, such as serious heart or brain issues, or if you have a history of chronic pain or are using pain medications daily, you may not be eligible. If you join the study, you will receive either the TENS treatment or the placebo, and the researchers will monitor your pain levels after your surgery to see how well the treatment works. This study aims to improve pain management options for patients undergoing lung surgery.

Gender

ALL

Eligibility criteria

  • Inclusion Criteria:
  • Patients aged over 18 years
  • American Society of Anesthesiologists (ASA) physical status of I-III
  • Patients scheduled for elective unilateral lobectomy via video-assisted thoracoscopic surgery (VATS) for lung cancer under general anesthesia
  • Informed consent signed
  • Exclusion Criteria:
  • History of liver, kidney, heart, lung, or brain disease
  • Psychiatric disorder or cognitive impairment
  • Chronic pain, daily use of analgesics, or alcohol dependence
  • Routine or recent acupuncture treatment
  • Contraindications to TENS (with pacemaker or metallic implants, allergy to surface electrodes, with skin sensory disorders, skin ulceration, unhealed scars, or adhesions)

About Changhai Hospital

Changhai Hospital is a leading medical institution dedicated to advancing healthcare through innovative research and clinical trials. With a commitment to excellence, the hospital integrates cutting-edge medical technologies and a multidisciplinary approach to patient care. Changhai Hospital actively collaborates with research organizations and healthcare professionals to conduct rigorous clinical trials aimed at developing new treatments and improving patient outcomes. By prioritizing patient safety and ethical standards, the hospital plays a pivotal role in contributing to the advancement of medical knowledge and the enhancement of therapeutic options.

Locations

Shanghai, Shanghai, China

Patients applied

0 patients applied

Trial Officials

Jiafeng Wang, M.D.

Principal Investigator

Changhai hospital, Shanghai, China

Timeline

First submit

Trial launched

Trial updated

Estimated completion

Not reported